These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 9126901)

  • 1. Hydroxyurea for treatment of unresectable and recurrent meningiomas. I. Inhibition of primary human meningioma cells in culture and in meningioma transplants by induction of the apoptotic pathway.
    Schrell UM; Rittig MG; Anders M; Kiesewetter F; Marschalek R; Koch UH; Fahlbusch R
    J Neurosurg; 1997 May; 86(5):845-52. PubMed ID: 9126901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydroxyurea for treatment of unresectable and recurrent meningiomas. II. Decrease in the size of meningiomas in patients treated with hydroxyurea.
    Schrell UM; Rittig MG; Anders M; Koch UH; Marschalek R; Kiesewetter F; Fahlbusch R
    J Neurosurg; 1997 May; 86(5):840-4. PubMed ID: 9126900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium channel antagonists augment hydroxyurea- and ru486-induced inhibition of meningioma growth in vivo and in vitro.
    Ragel BT; Gillespie DL; Kushnir V; Polevaya N; Kelly D; Jensen RL
    Neurosurgery; 2006 Nov; 59(5):1109-20; discussion 1120-1. PubMed ID: 17143245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stabilization of disease progression by hydroxyurea in patients with recurrent or unresectable meningioma.
    Mason WP; Gentili F; Macdonald DR; Hariharan S; Cruz CR; Abrey LE
    J Neurosurg; 2002 Aug; 97(2):341-6. PubMed ID: 12186462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydroxyurea chemotherapy in the treatment of meningiomas.
    Newton HB
    Neurosurg Focus; 2007; 23(4):E11. PubMed ID: 17961035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydroxyurea chemotherapy for unresectable or residual meningioma.
    Newton HB; Slivka MA; Stevens C
    J Neurooncol; 2000 Sep; 49(2):165-70. PubMed ID: 11206012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydroxyurea for treatment of unresectable meningiomas.
    Schrell UM; Rittig MG; Koch U; Marschalek R; Anders M
    Lancet; 1996 Sep; 348(9031):888-9. PubMed ID: 8826822
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of high risk or recurrent meningiomas with hydroxyurea.
    Rosenthal MA; Ashley DL; Cher L
    J Clin Neurosci; 2002 Mar; 9(2):156-8. PubMed ID: 11922703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxyurea with or without imatinib in the treatment of recurrent or progressive meningiomas: a randomized phase II trial by Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO).
    Mazza E; Brandes A; Zanon S; Eoli M; Lombardi G; Faedi M; Franceschi E; Reni M
    Cancer Chemother Pharmacol; 2016 Jan; 77(1):115-20. PubMed ID: 26659583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydroxyurea chemotherapy for meningiomas: enlarged cohort with extended follow-up.
    Newton HB; Scott SR; Volpi C
    Br J Neurosurg; 2004 Oct; 18(5):495-9. PubMed ID: 15799152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nelfinavir potentiation of imatinib cytotoxicity in meningioma cells via survivin inhibition.
    Gupta V; Samuleson CG; Su S; Chen TC
    Neurosurg Focus; 2007; 23(4):E9. PubMed ID: 17961046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Irinotecan: a potential new chemotherapeutic agent for atypical or malignant meningiomas.
    Gupta V; Su YS; Samuelson CG; Liebes LF; Chamberlain MC; Hofman FM; Schönthal AH; Chen TC
    J Neurosurg; 2007 Mar; 106(3):455-62. PubMed ID: 17367069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracranial injection of human meningioma cells in athymic mice: an orthotopic model for meningioma growth.
    McCutcheon IE; Friend KE; Gerdes TM; Zhang BM; Wildrick DM; Fuller GN
    J Neurosurg; 2000 Feb; 92(2):306-14. PubMed ID: 10659019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of proliferation of human cerebral meningioma cells by suramin: effects on cell growth, cell cycle phases, extracellular growth factors, and PDGF-BB autocrine growth loop.
    Schrell UM; Gauer S; Kiesewetter F; Bickel A; Hren J; Adams EF; Fahlbusch R
    J Neurosurg; 1995 Apr; 82(4):600-7. PubMed ID: 7897522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miRNA-145 is downregulated in atypical and anaplastic meningiomas and negatively regulates motility and proliferation of meningioma cells.
    Kliese N; Gobrecht P; Pachow D; Andrae N; Wilisch-Neumann A; Kirches E; Riek-Burchardt M; Angenstein F; Reifenberger G; Riemenschneider MJ; Meese E; Panayotova-Dimitrova D; Gutmann DH; Mawrin C
    Oncogene; 2013 Sep; 32(39):4712-20. PubMed ID: 23108408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trabectedin has promising antineoplastic activity in high-grade meningioma.
    Preusser M; Spiegl-Kreinecker S; Lötsch D; Wöhrer A; Schmook M; Dieckmann K; Saringer W; Marosi C; Berger W
    Cancer; 2012 Oct; 118(20):5038-49. PubMed ID: 22392434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor effects of antiprogesterones on human meningioma cells in vitro and in vivo.
    Matsuda Y; Kawamoto K; Kiya K; Kurisu K; Sugiyama K; Uozumi T
    J Neurosurg; 1994 Mar; 80(3):527-34. PubMed ID: 8113866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-resectable slow-growing meningiomas treated by hydroxyurea.
    Loven D; Hardoff R; Sever ZB; Steinmetz AP; Gornish M; Rappaport ZH; Fenig E; Ram Z; Sulkes A
    J Neurooncol; 2004; 67(1-2):221-6. PubMed ID: 15072471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of survivin and p16(INK4a)/Cdk6/pRB proteins and induction of apoptosis in response to radiation and cisplatin in meningioma cells.
    Al-Khalaf HH; Lach B; Allam A; Hassounah M; Alkhani A; Elkum N; Alrokayan SA; Aboussekhra A
    Brain Res; 2008 Jan; 1188():25-34. PubMed ID: 18048012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Celecoxib inhibits meningioma tumor growth in a mouse xenograft model.
    Ragel BT; Jensen RL; Gillespie DL; Prescott SM; Couldwell WT
    Cancer; 2007 Feb; 109(3):588-97. PubMed ID: 17177201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.